Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer

<div>The evaluation of prognostic signature in TCGA cohort. (a) The curve of risk score and BCR status of the patients. (b) ROC curve of model and clinical characteristics predicting 1-, 3-, and 5-year bRFS. (c) The bRFS analysis of the two subgroups stratified based on the median of risk scores calculated by the risk model. (d, e) Univariate and multivariate Cox regression analyses showed that the risk score had prominent prognostic values.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer 

Figure 5 | Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer 